Travaux publiés
Publications (2005 au présent)
= Texte intégral disponible
- Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada
BMC Health Services Research. 2011; [Epub ahead of print]
Tony M, Wagner M, Khoury H, Rindress D, Papastavros T, Oh P, Mireille Goetghebeur - Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): Applying the EVIDEM framework to medicines appraisal
Medical Decision Making 2011; [Epub ahead of print]
Goetghebeur MM, Wagner M, Khoury H, Levitt RJ, Erickson LJ, Rindress D - Characterization of the proportion of untreated and antiplatelet therapy treated patients with atrial fibrillation
American Journal of Cardiology. 2011;108(1):151-61.
Ogilvie I, Welner S, Cowell W, Lip G - Ischemic stroke and bleeding rates in 'real-world' atrial fibrillation patients
Thromb Haemost. 2011;106(1):34-44.
Ogilvie I, Welner S, Cowell W, Lip G - Disease burden and unmet needs for prevention of venous thromboembolism in medically ill patients in Europe show under-utilisation of preventive therapies
Thromb Haemost. 2011;106(4):1-9.
Khoury H, Welner S, Kubin M, Folkerts K, Haas S - Economic burden of herpes zoster among skilled nursing facility residents in the US
Journal of the American Medical Directors Association 2011; [Epub ahead of print]
Ma L, White R, Narayanan S, Schmader MD - Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis
Rheumatol Int 2011; [Epub ahead of print]
Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Tanaka Y, Yamanaka H, Fujii K, Yoshinaga T, Freundlich B, Suzukawa M - Burden of rotavirus gastroenteritis in the Middle Eastern and North African pediatric population
BMC Infectious Diseases 2011;11(9):1-11.
Khoury H, Ogilvie I, El Khoury A, Yinghui D, Goetghebeur M - Burden of rotavirus gastroenteritis in the pediatric population in central and eastern Europe: serotype distribution and burden of illness
Human Vaccines 2011;7(5):523-33.
Ogilvie I, Khoury H, El Khoury A, Goetghebeur M - Differences in biologic dose-escalation, non-biologic and steroid intensification among three anti-TNF agents: evidence from clinical practice
Clinical and Experimental Rheumatology 2011;29(1):26-34.
Moots R, Haraoui B, Matucci-Cerinic N, van Riel PL, Kekow J, Schaeverbeke T, Davis A, Tedeschi M, Freundlich B, Chang DJ, Singh A - Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis
Rheumatology 2010;50(2):401-09.
Kekow J, Moots R, Khandker R, Melin J, Freundlich B, Singh A - Health-related quality of life and healthcare resource use in European patients with plaque psoriasis: an association independent of observed disease severity
Clinical and Experimental Dermatology 2010 Jun 21;36(1):24-8.
Sato R, Milligan G, Molta C, Singh A - Underuse of oralanticoagulants in atrial fibrillation: a systematic review
The American Journal of Medicine 2010;123(7):638-45.
Ogilvie I, Newton N, Welner S, Cowell W, Lip G - Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patients
Cost Effectiveness and Resource Allocation 2010;8(1):4.
Goetghebeur M, Wagner M, Khoury H, Rindress D, Gregoire J-P, Deal C - Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: The COMET trial
Annals of the Rheumatic Diseases 2010;69(1):222-5.
Kekow J, Moots R, Emery P, Durez P, Koenig A, Singh A, Pedersen R, Robertson D, Freundlich B, Sato R - The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics
Journal of the European Academy of Dermatology and Venereology 2010;24:548-554.
Christophers E, Barker JNWN, Griffiths CEM, Dauden E, Milligan G, Molta C, Sato R, Boggs R - Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients
Journal of Gastroenterology and Hepatology 2009;25(5):892-8.
Suzuki F, Akuta N, Suzuki Y, Yatsuji H, Sezaki H, Arase Y, Hirakawa M, Kawamura Y, Hosaka T, Kobayashi M, Saitoh S, Ikeda K, Kobayashi M, Watahiki S, Kumada H - The ISPOR Good Practices for Quality Improvement of Cost-effectiveness Research Task Force Report
Value in Health 2009;12(8)
McGhan WF, Maiwenn A, Doshi JA, Kamae I, Marx SE, Rindress D - Venous leg ulcers: patient concordance with compression therapy and its impact on healing and prevention of recurrence
International Wound Journal 2009;6(5):386-93.
Moffatt C, Kommala D, Dourdin N, Choe Y - Cost-effectiveness of atorvastatin 10 mg daily in the primary prevention of major cardiovascular events in patients with type 2 diabetes in Canada
Canadian Journal of Diabetes 2009;33(4):363-74.
Khoury H, Wagner M, Merikle E, Johnson SJ, Roberts C - Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: A systematic review of conclusions and assumptions
Vaccine 2009;27(36):4891-904.
Ogilvie I, El Khoury A, Cui Y, Dasbach E, Grabenstein JD, Goetghebeur M - Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis
Arthritis & Rheumatism 2009;61(11):1592-600.
Kavanaugh A, Smolen JS, Emery P, Purcaru O, Keystone E, Richard L, Strand V, vanVollenhoven RF - Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada
Canadian Journal of Clinical Pharmacology 2009;16(2):e331-e345.
Wagner M, Goetghebeur M, Pandya A, Merikle E, Chu P, Taylor DCA - Economic evaluation of high-dose (80 mg/day) atorvastatin treatment compared with standard-dose (20 mg/day to 40 mg/day) simvastatin treatment in Canada based on the Incremental Decrease in End-Points Through Aggressive Lipid-Lowering (IDEAL) trial
Canadian Journal of Cardiology 2009;25(11):e362-e369.
Wagner M, Lindgren P, Merikle E, Goetghebeur M, Jonsson B - Worksite health promotion: the value of the Tune Up Your Heart program
Population Health Management 2009;12(6):297-304.
Chung M, Melnyk P, Blue D, Renaud D, Breton M-C
- Detection of Cognitive Impairment and Dementia Using the Animal Fluency Test: the DECIDE Study
Canadian Journal of Neurological Sciences 2009;36(5):599-604.
Sebaldt RJ, Dalzeil W, Massoud F, Tanguay A, Ward R, Thabane L, Melnyk P, Landry P, Lescrauwaet B - Post-marketing surveillance of the safety and effectiveness of etanercept in Japan
Journal of Rheumatology 2009:36(5);898-906
Koike T, Harigai M, Inokuma S, Ishiguro N, Inoue K, Ryu J, Takeuchi T, Tanaka Y, Yamanaka H, Fujii K, Freundlich B, Suzukawa M - A retrospective analysis of the prevalence and treatment of hypertension and dyslipidemia in southwestern Ontario, Canada
Clinical Therapeutics 2008;30(6):1145-54.
Petrella RJ, Merikle E - Chronic myeloid leukemia in Asia
International Journal of Hematology 2008;89(1):14-23.
Au WY, Caguioa PB, Chuah C, Hsu SC, Jootar S, Kim D-W, Kweon I-Y, O'Neil WM, Saikia TK, Wang J - Limitations of statin monotherapy for the treatment of dyslipidemia - a projection based on the Canadian Lipid Study Observational
Current Medical Research and Opinion 2008;25(1):47-55.
Senecal M, Fodor G, Gagné C, Genest J, Lavoie M-A, McPherson R, Marentette MA, Sebaldt RJ - Evidence and Value: Impact on DEcisionMaking - the EVIDEM framework and potential applications
BMC Health Services Research 2008;8:270.
Goetghebeur M, Wagner M, Khoury H, Levitt R, Erickson LJ, Rindress D - Fentanyl HCl iontophoretic transdermal system versus morphine IV-PCA for postoperative pain management: survey of healthcare provider opinion
Current Medical Research and Opinion 2008;25(2):293-301.
Bonnet F, Eberhart L, Wennberg E, Dodds S, VanBellinghen L, Annemans L, Kavanaugh S, Choe Y - Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study
(includes editorial)
Canadian Respiratory Journal 2008;15(1):13-9.
Bourbeau J, Sebaldt RJ, Day A, Bouchard J, Kaplan A, Hernandez P, Rouleau M, Petrie A, Foster G, Thabane L, Haddon J, Scalera A - Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study
Canadian Journal of Infectious Disease and Medical Microbiology 2008;19(6):397-404.
Senecal M, Brisson M, the MIRAGE (Measuring the Impact of Rotavirus-Associated Gastroenteritis Episodes) study group, Lebel MH, Yaremko J, Wong R, Gallant L, Garfield HA, Abelman DJ, Ward RL, Sampalis J, Mansi JA - Burden of illness of neovascular age-related macular degeneration in Canada
Canadian Journal of Ophthalmology 2007;42(6):836-43.
Cruess A, Zlateva G, Xu X, Rochon S - Influence of medication choice and comorbid diabetes: the cost of bipolar disorder in a privately insured US population
Social Psychiatry & Psychiatric Epidemiology 2007 Sep;42(9):690-7.
Harley C, Li H, Corey-Lisle.P., L'Italien GJ, Carson W - A model for assessing the cost-effectiveness of atorvastatin and simvastatin in achieving Canadian low-density lipoprotein cholesterol targets
Clin Ther 2007;29(3):519-28.
Lachaine J, Merikle E, Tarride JE, Montpetit M, Rinfret S - Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly
Rheumatology (Oxford) 2007;49(6):999-1004.
Braun J, McHugh N, Singh A, Wajdula JS, Sato R - Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer
Cancer 2007;110(3):499-508.
Risebrough NA, Verma S, Trudeau M, Mittman N - Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis
Clin Ther 2007;29(4):742-50.
Petrella RJ, Merikle E, Jones J - Cost-effectiveness of letrozole in the extended adjuvant treatment of women with early breast cancer
Breast Cancer Res Treat 2007;101(1):37-49.
El Ouagari K, Karnon J, Delea TE, Talbot W, Brandman JB - Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial
Annals for Rheumatic Disease 2008;67(8):1104-1110.
van Riel PL, Freundlich B, MacPeek D, Pedersen R, Foehl JR, Singh A - Patient reported outcomes and health-related quality of life in effectiveness studies: pros and cons
Drug Development Research. 2007;67(3):193-201.
Marquis P, Acquadro C, Roberts M. - Methicillin-resistant staphylococcus aureus: a public health issue with economic consequences
Canadian Journal of Infectious Disease and Medical Microbiology. 2007;18(1):27-34.
Goetghebeur M, Landry A, Han D, Vicente C - Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study
Rheumatology (Oxford) 2007;46(2):265-72.
Rahme E, Bardou M, Dasgupta K, Toubouti Y, Ghosn J, Barkun AN - Increase in nonfatal digestive perforations and haemorrhages following introduction of selective NSAIDs
Drug Safety. 2006;29(7):613-20.
Barnard L, Lavoie D, Lajeunesse.N - Modeling and cost-effectiveness analysis of etanercept in adults with rheumatoid arthritis in Japan: a preliminary analysis
Modern Rheumatology. 2006;16(2):77-84.
Tanno M, Nakamura I, Ito K, Tanaka H, Ohta H, Kobayashi M, et al. - Effects of antisense oligodeoxynucleotides targeting CCR3 on the airway response to antigen in rats
Oligonucleotides. 2006;16(3):203-12.
Fortin M, Ferrari N, Higgins ME, Seguin S, Allam M, Allakhverdi Z, et al. - Evidence of Cost Shifting In California Hospitals
Health Affairs 2006;25(1):197-203.
Zwanziger J, Bamezai A - Therapy switching and associated costs in elderly patients receiving COX-2 selective inhibitors or nonselective nonsteroidal anti-inflammatory drugs in Quebec, Canada
Rheumatology (Oxford) 2006;45(7):903-10.
Rahme E, Toubouti Y, Hunsche E - Utilization and cost comparison of current and optimal prescribing of nonsteroidal anti-inflammatory drugs in Quebec, Canada
Journal of Rheumatology 2006;33(3):588-96.
Rahme E, Toubouti Y, LeLorier J - Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis
Arthritis & Rheumatism 2006;55(2):287-93.
Moreland LW, Genovese MC, Sato R, Singh A - Retrospective analysis of utilization patterns and cost implications of coxibs among seniors in Quebec, Canada: what is the potential impact of the withdrawal of rofecoxib?
Arthritis & Rheumatism 2006;55(1):27-34.
Rahme E, Hunsche E, Toubouti Y, Chabot I - Patient-reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial
Annals of Rheumatic Diseases 2006;65(3):328-34.
van der Heijde D, Klareskog L, Singh A, Tornero J, Melo-Gomes J, Codreanu C, Pedersen R, Freundlich B, Fatenejad S - Burden of atopic dermatitis in Canada
International Journal of Dermatology 2006;45(1):31-36.
Barbeau M, Lalonde H - Statin therapy in Canadian patients with hypercholesterolemia: The Canadian Lipid Study-Observational (CALIPSO)
Canadian Journal of Cardiology 2005;21(13):1187-93.
Bourgault C, Davignon J, Fodor G, Gagné C, Gaudet D, Genest J, Lavoie M-A, Leiter L, McPherson R, Senecal M, Marentette M, Sebaldt R - Economic impact of the reduced incidence of atrial fibrillation in patients with heart failure treated with enalapril
American Heart Journal 2005;150:985.e1-985.e8.
Wagner M, Rindress D, Desjardins B, Meilleur M-C, Ducharme A, Tardif JC - Pharmacokinetics of proton pump inhibitors in children
Clin Pharmacokinet 2005;44(5):441-66. Review.
Litalien C, Théorêt Y, Faure C - Implementation and outcomes of commercial disease management programs in the United States:
the Disease Management Outcomes Consolidation Survey
Disease Management 2005;8(4):253-64
Fitzner K, Fox K, Schmidt J, Roberts M, Rindress D, Hay J - Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative
assessment of response to antipsychotics in patients with schizophrenia and schizoaffective
disorder
Psychiatry Research 2005;136:211-221.
Tandon R, DeVellis RF, Han J, Li H, Frangou S, Dursun S - Medicare coverage and reimbursement of outpatient prescription drugs in the US:
history, recent changes and outlook for the future
Applied Health Economics and Health Policy 2005;4(1):9-14.
Forrest S, Goetghebeur MM, Hay J - The value of medicines in Canada
Canadian Journal of Clinical Pharmacology 2005;12(1):e10-e21.
Han D, Wang E